|
|
Volumn 17, Issue 11, 1996, Pages 400-
|
|
Pharmacokinetics of fluoxetine [1]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBAMAZEPINE;
CITALOPRAM;
DRUG METABOLITE;
FLUOXETINE;
FLUVOXAMINE;
LITHIUM;
MONOAMINE OXIDASE INHIBITOR;
NORFLUOXETINE;
PAROXETINE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
TRICYCLIC ANTIDEPRESSANT AGENT;
TRYPTOPHAN;
DRUG BLOOD LEVEL;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG METABOLISM;
DRUG WITHDRAWAL;
HUMAN;
LETTER;
PRESCRIPTION;
PRIORITY JOURNAL;
RISK;
WITHDRAWAL SYNDROME;
DRUG INTERACTION;
HALF LIFE TIME;
METABOLISM;
DRUG INTERACTIONS;
FLUOXETINE;
HALF-LIFE;
HUMANS;
SEROTONIN UPTAKE INHIBITORS;
SUBSTANCE WITHDRAWAL SYNDROME;
|
|
EID: 0030277462
PISSN: 01656147
EISSN: None
Source Type: Journal
DOI: 10.1016/0165-6147(97)81408-3 Document Type: Letter |
|
Times cited : (4)
|
|
References (7)
|
